Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Itsaso Cabezón"'
Publikováno v:
Immunity & Ageing, Vol 19, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/2efe9c48de3d4a7e801f006b0c25b85c
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Brain ageing in mice leads to the progressive appearance and expansion of degenerative granular structures frequently referred as "PAS granules" because of their positive staining with periodic acid-Schiff (PAS). PAS granules are present mainly in th
Autor:
Jordi Duran, Gemma Manich, Itsaso Cabezón, Jordi Vilaplana, Elisabet Augé, Joan J. Guinovart, Carme Pelegrí
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Lafora disease (LD), the most devastating adolescence-onset epilepsy, is caused by mutations in the EPM2A or EPM2B genes, which encode the proteins laforin and malin, respectively. Loss of function of one of these proteins, which are involved in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3e4b79a3c3eb360740f610dc63007b8
http://hdl.handle.net/2445/169100
http://hdl.handle.net/2445/169100
Publikováno v:
Scientific Reports
Corpora amylacea are structures of unknown origin and function that appear with age in human brains and are profuse in selected brain areas in several neurodegenerative conditions. They are constituted of glucose polymers and may contain waste elemen
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Immunity & Ageing : I & A
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Immunity & Ageing : I & A
Background: Degenerative granular structures appear progressively with age in the hippocampus of most mouse strains. We recently reported that these granules contain a neo-epitope that is recognised by IgM antibodies present as contaminants in many c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c55d0059f3c26a15451b0f69a3b7724a
http://hdl.handle.net/2445/100550
http://hdl.handle.net/2445/100550
Autor:
Carme Pelegrí, Raquel Martín-Venegas, Gemma Manich, Jordi Vilaplana, Itsaso Cabezón, Antoni Camins
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Receptor-mediated transcytosis has been widely studied as a possible strategy to transport neurotherapeutics across the blood-brain barrier (BBB). Monoclonal antibodies directed against the transferrin receptor (TfR) have been proposed as potential c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b126387ccd694d0d93d5c1a5563b97c
http://hdl.handle.net/2445/169368
http://hdl.handle.net/2445/169368
Autor:
Pawel P. Liberski, Jordi Vilaplana, Gemma Manich, Mercè Pallàs, Carme Pelegrí, Itsaso Cabezón, Antoni Camins
Publikováno v:
AGE. 36
Clusters of pathological granular structures appear and progressively increase in number with age in the hippocampus of several mice strains, markedly in the senescence-accelerated mouse prone 8 mice. In the present work, we performed an ultrastructu
Autor:
Jordi Vilaplana, Mercè Pallàs, Carme Pelegrí, Itsaso Cabezón, Gemma Manich, Antoni Camins, Jaume del Valle
Clustered pathological granules related to a degenerative process appear and increase progressively with age in the hippocampus of numerous mouse strains. We describe herein the presence of a neo-epitope of carbohydrate nature in these granules, whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::887e8b4a518b5a270aee6dfe67790ae7
https://europepmc.org/articles/PMC3889905/
https://europepmc.org/articles/PMC3889905/
Autor:
Jordi Vilaplana, Mercè Pallàs, Carme Pelegrí, Joaquim Duran-Vilaregut, Gemma Manich, Itsaso Cabezón, Antoni Camins, Jaume del Valle
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 49(4)
One strategy used to transport pharmacologically active substances across the blood-brain barrier (BBB) is to link the substance to a molecule capable of crossing the BBB using a receptor-mediated transcellular transport system in brain capillary end